⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL960217 | 1.00 | — | — | |
| SCHEMBL962192 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL21175423 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL292019 | 0.97 | — | — | |
| Nitric Acid SCHEMBL14696431 | 0.81 | CA5A (0.35) | — | |
| SCHEMBL31472174 | 0.79 | — | — | |
| Trifluoroacetic Acid SCHEMBL4331701 | 0.78 | DPP4 (0.37) | — | |
| SCHEMBL12868512 | 0.75 | — | — | |
| SCHEMBL11632373 | 0.75 | — | — | |
| SCHEMBL1345692 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119913220-A | Method for preparing GLP-1 receptor agonist intermediate | 宁波酶赛生物工程有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-112020507-B | Amide compound and method for producing polynucleotide using same | 住友化学株式会社 | 2023-10-10 | — | — | CN | claimed |
| CN-114573569-B | Preparation method of isoquinoline compound | 邦恩泰(山东)生物医药科技集团股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-101838681-A | High-throughput screening method of nitrile invertase | UNIV ZHEJIANG TECHNOLOGY | 2010-09-22 | — | — | CN | claimed |
| CN-101417954-A | Method for preparing optically pure 3-amino butyl alcohol | SHANGHAI ABA CHEMICAL CO LTD (CN) | 2009-04-29 | — | — | CN | claimed |
| WO-2007144699-A2 | PROCESS FOR THE PREPARATION OF ALFUZOSIN | TORRENT PHARMACEUTICALS LIMITED (US) | 2007-12-21 | — | — | WO | claimed |
| US-20070105880-A1 | PROCESS FOR THE PREPARATION OF ALFUZOSIN | TORRENT PHARMACEUTICALS LIMITED (IN) | 2007-05-10 | — | — | US | claimed |
| JP-54112872-A | — | — | None | — | — | JP | disclosed |
| US-20260138998-A1 | GLP-1 RECEPTOR AGONISTS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12473301-B2 | Isoquinoline compounds for the treatment of cancer | GENENTECH, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| CN-119913220-A | Method for preparing GLP-1 receptor agonist intermediate | 宁波酶赛生物工程有限公司 | 2025-05-02 | — | — | CN | disclosed |
| EP-4097099-B9 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO INC (US) | 2025-04-30 | — | — | EP | disclosed |
| EP-3860995-B1 | ISOQUINOLINE COMPOUNDS FOR THE TREATMENT OF CANCER | HOFFMANN LA ROCHE (CH) | 2025-04-16 | — | — | EP | disclosed |
| US-4099955-A | N-(1-CYANO-3-METHYLTHIOPROPYL)UREAS | PHILAGRO (FR) | 1978-07-11 | — | — | US | disclosed |
| US-4064164-A | SEQUESTERING AGENTS, ANTICARIES AGENTS, CALCIUM OR PHOSPHATE METABOLISM ABNORMALITIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DT) | 1977-12-20 | — | — | US | disclosed |
| US-4038414-A | ANTIARRHYTHMIA AGENTS | CIBA-GEIGY CORPORATION (US) | 1977-07-26 | — | — | US | disclosed |
| US-4025507-A | OPTICAL BRIGHTENERS FOR PAPER | SANDOZ LTD. (CH) | 1977-05-24 | — | — | US | disclosed |
| US-4021224-A | THIOCARBAMATE, WEED PEST CONTROL, ANTIDOTES | STAUFFER CHEMICAL COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
| US-4014920-A | N-cinnamylcarbamic acid esters | CIBA-GEIGY CORPORATION (US) | 1977-03-29 | — | — | US | disclosed |
| US-3949088-A | Substituted phenoxy propanol amines used for treating cardiovascular diseases | SAMUELSSON BENNY ROGER | 1976-04-06 | — | — | US | disclosed |